Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation, X‐irradiation and glucocorticoids

British Journal of Haematology

Volumn 91, Issue 2, 1995, Pages 387-393

  Amos, T A S ^a   Lewis, J L ^a   Grand, F H ^a   Gooding, R P ^b   Goldman, J M ^a   Gordon, M Y ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

apoptosis; CML; glucocorticoids; growth factors; X irradiation

Indexed keywords

GLUCOCORTICOID; GROWTH FACTOR; HYDROCORTISONE; METHYLPREDNISOLONE;

APOPTOSIS; ARTICLE; CHRONIC MYELOID LEUKEMIA; COLONY FORMING UNIT GM; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; STEM CELL; X RAY;

APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, RADIATION; ERYTHROID PROGENITOR CELLS; GROWTH SUBSTANCES; HUMAN; HYDROCORTISONE; LEUKEMIA, MYELOID, CHRONIC; METHYLPREDNISOLONE; SUPPORT, NON-U.S. GOV'T;

EID: 0028861070     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1995.tb05308.x     Document Type: Article

References (43)

1. Cell kinetics of leukemia
2. Deficient cell cycle control in immature hematopoietic cells of patients with newly diagnosed chronic myeloid leukemia
3. Successful autografting in chronic myeloid leukemia after maintenance of marrow in culture
4. Inhibition of apoptosis by BCR‐ABL in chronic myeloid leukemia
5. The chronic myelogenous leukemia‐specific p210 protein is the product of the bcr‐abl hybrid gene
6. A mathematical model of chronic myelogenous leukemia (CML) chronic phase
7. Effects of interleukin 3 and c‐kit ligand on the survival of various classes of human hematopoietic progenitor cells
8. Transformation of an interleukin‐3 dependent hematopoietic cell line by the chronic myelogenous leukemia‐specific p210 bcr/abl protein
9. Drug‐target interactions: only the first step in the commitment to a programmed cell death
10. Kinetics of bone marrow cell production in human acute and chronic myeloid leukemias
11. Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells
12. Selective hypersensitivity to granulocyte‐macrophage colony‐stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors
13. p210 Bcr‐abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogene
14. Initiation of deregulated growth of multipotent progenitor cells by bcr‐abl
15. Plastic‐adherent cells in human bone marrow generate long‐term hematopoiesis in vitro
16. An in vitro model for the production of haematopoietic progenitor cells stimulated by exposure to single and combined recombinant growth factors
17. Plastic‐adherent progenitor cells in human bone marrow
18. Philadelphia chromosomal breakpoints are clustered within a limited region, bar, on chromosome 22
19. bcr‐abl oncogene renders myeloid cell line factor independent: potential autocrine mechanisms in chronic myeloid leukemia
20. Bcl‐2 is an inner mitochondrial membrane protein that blocks programmed cell death
21. DNA‐flow cytometry of blood and bone marrow in chronic myelogenous leukemia
22. Bcl‐2 initiates a new category of oncogenes: regulation of cell death
23. Programmed cell death (apoptosis) in hematopoiesis
24. Pluripotent hemopoietic progenitors (CFU‐GEMM) in chronic myelogenous leukemia
25. The kinetics of colony formation by CFU‐GM
26. P53 is required for radiation induced apoptosis in mouse thymocytes
27. BCR/ABL confers factor independence upon a murine myeloid cell line
28. High gradient magnetic cell separation with MACS
29. A cell line secreting stimulating factors for CFU‐GEMM culture
30. A minute chromosome in human chronic granulocytic leukemia
31. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
32. Control of programmed cell death in normal and leukemic cells: new implications for therapy
33. Expression of p210 BCR/ABL increases hematopoietic progenitor cell radiosensitivity
34. Chronic myelogenous leukemia: in vitro studies on hematopoietic regulation in a patient undergoing intensive chemotherapy
35. Biology of chronic myelogenous leukemia: Is discordant maturation the primary defect
36. Cell kinetics in chronic granulocytic leukaemia (CGL)
37. Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia
38. Selective inhibition of leukemia cell proliferation by BCR‐ABL antisense oligonucleotides
39. Rapid decline of chronic myeloid leukemic cells in long‐term culture due to a defect at the stem cell level
40. Programmed cell death: apoptosis and oncogenesis
41. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis
42. Glucocorticoid‐induced thymocyte apoptosis is associated with endogenous nuclease activation